Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 14 studies | 32% ± 11% | |
| basal cell | 4 studies | 22% ± 2% | |
| club cell | 4 studies | 18% ± 1% | |
| epithelial cell | 4 studies | 39% ± 8% | |
| enterocyte | 4 studies | 24% ± 4% | |
| respiratory goblet cell | 3 studies | 20% ± 5% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 3 studies | 19% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| stomach | 75% | 1250.93 | 269 / 359 | 89% | 32.66 | 254 / 286 |
| breast | 53% | 530.24 | 242 / 459 | 83% | 71.78 | 932 / 1118 |
| intestine | 44% | 769.87 | 422 / 966 | 91% | 38.13 | 479 / 527 |
| pancreas | 39% | 161.43 | 127 / 328 | 70% | 14.78 | 124 / 178 |
| thymus | 41% | 194.30 | 270 / 653 | 66% | 9.50 | 402 / 605 |
| bladder | 38% | 632.81 | 8 / 21 | 65% | 21.04 | 328 / 504 |
| ureter | 0% | 0 | 0 / 0 | 100% | 49.64 | 1 / 1 |
| esophagus | 38% | 1212.82 | 554 / 1445 | 60% | 18.28 | 109 / 183 |
| brain | 74% | 886.41 | 1946 / 2642 | 7% | 0.57 | 52 / 705 |
| uterus | 39% | 186.09 | 66 / 170 | 41% | 13.42 | 187 / 459 |
| prostate | 30% | 174.34 | 73 / 245 | 47% | 6.35 | 238 / 502 |
| skin | 72% | 3493.61 | 1305 / 1809 | 4% | 0.81 | 20 / 472 |
| kidney | 47% | 435.53 | 42 / 89 | 23% | 4.55 | 210 / 901 |
| ovary | 2% | 7.61 | 4 / 180 | 58% | 11.27 | 251 / 430 |
| lung | 14% | 104.51 | 81 / 578 | 39% | 8.88 | 455 / 1155 |
| tonsil | 0% | 0 | 0 / 0 | 47% | 8.15 | 21 / 45 |
| liver | 0% | 1.67 | 1 / 226 | 7% | 1.81 | 29 / 406 |
| adrenal gland | 0% | 1.93 | 1 / 258 | 1% | 0.28 | 3 / 230 |
| adipose | 1% | 5.61 | 9 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 1% | 3.98 | 9 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 0% | 1.27 | 1 / 241 | 0% | 0 | 0 / 0 |
| muscle | 0% | 1.07 | 1 / 803 | 0% | 0 | 0 / 0 |
| heart | 0% | 0.36 | 1 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0.52 | 1 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0030148 | Biological process | sphingolipid biosynthetic process |
| GO_0006667 | Biological process | sphinganine metabolic process |
| GO_0046513 | Biological process | ceramide biosynthetic process |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0042284 | Molecular function | sphingolipid delta-4 desaturase activity |
| GO_0000170 | Molecular function | sphingosine hydroxylase activity |
| GO_0102772 | Molecular function | sphingolipid C4-monooxygenase activity |
| Gene name | DEGS2 |
| Protein name | Delta 4-desaturase, sphingolipid 2 Sphingolipid delta(4)-desaturase/C4-monooxygenase DES2 (EC 1.14.18.5) (EC 1.14.19.17) (Degenerative spermatocyte homolog 2) (Sphingolipid 4-desaturase) (Sphingolipid C4-monooxygenase) |
| Synonyms | C14orf66 |
| Description | FUNCTION: Bifunctional enzyme which acts both as a sphingolipid delta(4)-desaturase and a sphingolipid C4-monooxygenase. . |
| Accessions | ENST00000553834.1 ENST00000305631.7 Q6QHC5 G3V2F9 |
